Construction of a fusion protein between N-terminal 153 peptide of thrombopoietin and erythropoietin

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  C. Begley,et al.  Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer , 1996, The Lancet.

[3]  H. Miyazaki,et al.  In Vivo Effects of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor on Hematopoiesis in Normal Mice , 1996, Stem cells.

[4]  D. Lacey,et al.  Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. , 1995, Blood.

[5]  H. Samonigg,et al.  Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy , 1995, Cancer.

[6]  M. C. Hu,et al.  Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI , 1994, Cell.

[7]  V. Broudy,et al.  Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin , 1994, Nature.

[8]  D. Goeddel,et al.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand , 1994, Nature.

[9]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Clark Da,et al.  Effects of recombinant erythropoietin on murine megakaryocytic colony formation in vitro. , 1986 .

[11]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[12]  D. Metcalf,et al.  The effects of acute thrombocytopenia on megakaryocyte-CFC and granulocyte-macrophage-CFC in mice: studies of bone marrow and spleen. , 1980, Blood.

[13]  N. Iscove,et al.  THE ROLE OF ERYTHROPOIETIN IN REGULATION OF POPULATION SIZE AND CELL CYCLING OF EARLY AND LATE ERYTHROID PRECURSORS IN MOUSE BONE MARROW , 1977, Cell and tissue kinetics.

[14]  A. V. van Kaam,et al.  Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy , 1996, Cancer.

[15]  H. Miyazaki,et al.  Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. , 1995, Blood.

[16]  H. Lu,et al.  Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. , 1994, Cell.

[17]  D. Clark,et al.  Effects of recombinant erythropoietin on murine megakaryocytic colony formation in vitro. , 1986, The Journal of laboratory and clinical medicine.